Source: Υπουργείο Υγείας (CY) Publisher: OM PHARMA S.A., R. da Indústria, 2 – Quinta Grande, 2610-088 Аmadora Portugal
DICYNONE 500.
| Pharmaceutical Form |
|---|
|
Tablets. |
Active principle: etamsylate 500 mg.
Excipient with known effect: sodium sulfite (E221).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Etamsylate |
Etamsylate is a synthetic antihaemorrhagic and angioprotective drug acting on the first step of haemostasis (endothelium-platelet interaction). By improving platelet adhesiveness and restoring capillary resistance, it is able to reduce bleeding time and blood losses. |
| List of Excipients |
|---|
|
Maize starch |
Blister-packs of 10 tablets:
Box of 20 tablets.
Not all pack sizes may be marketed.
OM PHARMA S.A., R. da Indústria, 2 – Quinta Grande, 2610-088 Аmadora – Portugal
14836
Date of first authorisation: 5 July 1994
| Drug | Countries | |
|---|---|---|
| DICYNONE | Cyprus, Ecuador, Estonia, France, Lithuania, Mexico, Singapore, Tunisia |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
